Annual Current Liabilities
$53.27 M
-$11.94 M-18.32%
31 December 2023
Summary:
Rigel Pharmaceuticals annual total current liabilities is currently $53.27 million, with the most recent change of -$11.94 million (-18.32%) on 31 December 2023. During the last 3 years, it has risen by +$12.43 million (+30.43%). RIGL annual current liabilities is now -18.32% below its all-time high of $65.21 million, reached on 31 December 2022.RIGL Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$54.31 M
-$4.34 M-7.39%
30 September 2024
Summary:
Rigel Pharmaceuticals quarterly total current liabilities is currently $54.31 million, with the most recent change of -$4.34 million (-7.39%) on 30 September 2024. Over the past year, it has increased by +$6.04 million (+12.51%). RIGL quarterly current liabilities is now -52.83% below its all-time high of $115.15 million, reached on 31 March 2010.RIGL Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RIGL Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.3% | +12.5% |
| 3 y3 years | +30.4% | -8.4% |
| 5 y5 years | +92.1% | +75.2% |
RIGL Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -18.3% | +30.4% | -25.8% | +23.4% |
| 5 y | 5 years | -18.3% | +92.1% | -25.8% | +75.2% |
| alltime | all time | -18.3% | +561.4% | -52.8% | +691.3% |
Rigel Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $54.31 M(-7.4%) |
| June 2024 | - | $58.65 M(-19.9%) |
| Mar 2024 | - | $73.20 M(+37.4%) |
| Dec 2023 | $53.27 M(-18.3%) | $53.27 M(+10.3%) |
| Sept 2023 | - | $48.27 M(+9.7%) |
| June 2023 | - | $44.02 M(-3.3%) |
| Mar 2023 | - | $45.52 M(-30.2%) |
| Dec 2022 | $65.21 M(+2.6%) | $65.21 M(+38.0%) |
| Sept 2022 | - | $47.27 M(-14.0%) |
| June 2022 | - | $54.95 M(-7.2%) |
| Mar 2022 | - | $59.23 M(-6.8%) |
| Dec 2021 | $63.55 M(+55.6%) | $63.55 M(+7.2%) |
| Sept 2021 | - | $59.28 M(-0.4%) |
| June 2021 | - | $59.54 M(+14.5%) |
| Mar 2021 | - | $52.02 M(+27.4%) |
| Dec 2020 | $40.84 M(-29.8%) | $40.84 M(+19.4%) |
| Sept 2020 | - | $34.19 M(-1.6%) |
| June 2020 | - | $34.76 M(+11.5%) |
| Mar 2020 | - | $31.17 M(-46.5%) |
| Dec 2019 | $58.21 M(+109.9%) | $58.21 M(+87.7%) |
| Sept 2019 | - | $31.01 M(+9.3%) |
| June 2019 | - | $28.38 M(+8.6%) |
| Mar 2019 | - | $26.14 M(-5.8%) |
| Dec 2018 | $27.73 M(+51.2%) | $27.73 M(+40.8%) |
| Sept 2018 | - | $19.70 M(+13.4%) |
| June 2018 | - | $17.36 M(-7.6%) |
| Mar 2018 | - | $18.79 M(+2.5%) |
| Dec 2017 | $18.34 M(-18.8%) | $18.34 M(+22.2%) |
| Sept 2017 | - | $15.01 M(-5.5%) |
| June 2017 | - | $15.87 M(-8.0%) |
| Mar 2017 | - | $17.25 M(-23.7%) |
| Dec 2016 | $22.59 M(-33.2%) | $22.59 M(+9.5%) |
| Sept 2016 | - | $20.63 M(-6.2%) |
| June 2016 | - | $22.00 M(-20.6%) |
| Mar 2016 | - | $27.71 M(-18.0%) |
| Dec 2015 | $33.80 M(+141.0%) | $33.80 M(-3.0%) |
| Sept 2015 | - | $34.84 M(+1.9%) |
| June 2015 | - | $34.17 M(-0.5%) |
| Mar 2015 | - | $34.35 M(+144.9%) |
| Dec 2014 | $14.03 M(+36.2%) | $14.03 M(+37.5%) |
| Sept 2014 | - | $10.20 M(+1.4%) |
| June 2014 | - | $10.06 M(+28.0%) |
| Mar 2014 | - | $7.87 M(-23.6%) |
| Dec 2013 | $10.29 M(-15.7%) | $10.29 M(+24.0%) |
| Sept 2013 | - | $8.30 M(-2.0%) |
| June 2013 | - | $8.47 M(-7.5%) |
| Mar 2013 | - | $9.16 M(-25.0%) |
| Dec 2012 | $12.20 M | $12.20 M(+15.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $10.59 M(+11.4%) |
| June 2012 | - | $9.50 M(+18.2%) |
| Mar 2012 | - | $8.04 M(-30.3%) |
| Dec 2011 | $11.53 M(+1.8%) | $11.53 M(+36.9%) |
| Sept 2011 | - | $8.42 M(+8.2%) |
| June 2011 | - | $7.79 M(+10.6%) |
| Mar 2011 | - | $7.04 M(-37.8%) |
| Dec 2010 | $11.33 M(-36.3%) | $11.33 M(-81.8%) |
| June 2010 | - | $62.30 M(-45.9%) |
| Mar 2010 | - | $115.15 M(+547.9%) |
| Dec 2009 | $17.77 M(-26.4%) | $17.77 M(-12.5%) |
| Sept 2009 | - | $20.31 M(+4.0%) |
| June 2009 | - | $19.53 M(-0.9%) |
| Mar 2009 | - | $19.70 M(-18.4%) |
| Dec 2008 | $24.15 M(+49.9%) | $24.15 M(+8.1%) |
| Sept 2008 | - | $22.34 M(+36.5%) |
| June 2008 | - | $16.36 M(+39.1%) |
| Mar 2008 | - | $11.76 M(-27.0%) |
| Dec 2007 | $16.11 M(+43.4%) | $16.11 M(+98.3%) |
| Sept 2007 | - | $8.13 M(+10.4%) |
| June 2007 | - | $7.36 M(-16.9%) |
| Mar 2007 | - | $8.86 M(-21.2%) |
| Dec 2006 | $11.24 M(-52.5%) | $11.24 M(+4.7%) |
| Sept 2006 | - | $10.74 M(-16.1%) |
| June 2006 | - | $12.80 M(-36.6%) |
| Mar 2006 | - | $20.18 M(-14.6%) |
| Dec 2005 | $23.65 M(+107.1%) | $23.65 M(+56.2%) |
| Sept 2005 | - | $15.14 M(-3.1%) |
| June 2005 | - | $15.62 M(+5.1%) |
| Mar 2005 | - | $14.86 M(+30.2%) |
| Dec 2004 | $11.42 M(+41.8%) | $11.42 M(+46.0%) |
| Sept 2004 | - | $7.82 M(+1.4%) |
| June 2004 | - | $7.71 M(+2.1%) |
| Mar 2004 | - | $7.55 M(-6.2%) |
| Dec 2003 | $8.05 M(-44.0%) | $8.05 M(-10.8%) |
| Sept 2003 | - | $9.03 M(-2.7%) |
| June 2003 | - | $9.28 M(-11.1%) |
| Mar 2003 | - | $10.44 M(-27.3%) |
| Dec 2002 | $14.37 M(+41.4%) | $14.37 M(-12.7%) |
| Sept 2002 | - | $16.46 M(+1.3%) |
| June 2002 | - | $16.26 M(+3.8%) |
| Mar 2002 | - | $15.67 M(+54.2%) |
| Dec 2001 | $10.16 M(+26.1%) | $10.16 M(+1.2%) |
| Sept 2001 | - | $10.05 M(+46.4%) |
| June 2001 | - | $6.86 M(-10.5%) |
| Mar 2001 | - | $7.67 M(-4.8%) |
| Dec 2000 | $8.06 M(-15.4%) | $8.06 M |
| Dec 1999 | $9.52 M | - |
FAQ
- What is Rigel Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals annual current liabilities year-on-year change?
- What is Rigel Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals quarterly current liabilities year-on-year change?
What is Rigel Pharmaceuticals annual total current liabilities?
The current annual current liabilities of RIGL is $53.27 M
What is the all time high annual current liabilities for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high annual total current liabilities is $65.21 M
What is Rigel Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, RIGL annual total current liabilities has changed by -$11.94 M (-18.32%)
What is Rigel Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of RIGL is $54.31 M
What is the all time high quarterly current liabilities for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high quarterly total current liabilities is $115.15 M
What is Rigel Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, RIGL quarterly total current liabilities has changed by +$6.04 M (+12.51%)